TABLE 2.
Target gene | PCR primer
|
Relevant characteristic | PCR fragment size (bp) | |
---|---|---|---|---|
Namea | Nucleotide sequenceb | |||
hrcJ | HrcJ-F | GGACTAGTCCTGCTGCATGCGGGCGTGGA | SpeI site | 335 |
HrcJ-R | CCGCTCGAGCGGGAAAGCGGGTCGTTGTTGG | XhoI site | ||
HrcJ-ext-F | CATGACGCTCATTCCTCCTGT | To be used with ProR | 891 | |
hrcR | HrcR-F | GGACTAGTCCGCTGGTGGTCATCATGCTGG | SpeI site | 293 |
HrcR-R2 | CCGCTCGAGCGGTGTTTGAGGAGGAATTGC | XhoI site | ||
HrcR-ext-R | TCACCGATAGCTCAGAACCAGG | To be used with ProF | 756 | |
hrcT | HrcT-F | GGACTAGTCCCCTCGCAGGGCGTGTCGCTG | SpeI site | 329 |
HrcT-R2 | CCGCTCGAGCGGGTCATCTGCACATTGTTGTA | XhoI site | ||
HrcT-ext-R | CGTTGGCGGCATCGTGCAAT | To be used with ProF | 850 | |
hrcV | HrcV-F | CGGGATCCCGATTCGCAAAAACGCCCCTGATT | BamHI site | 454 |
HrcV-R | GGTCTAGAGCCAGCAGACGCCGCAACACAT | XbaI site | ||
HrcV-ext-F | TGGCCAACGAGAACGAGACAAG | To be used with ProR | 789 | |
hrpB2 | HrpB2-F | GGACTAGTCCATGACGCTCATTCCTCCTGT | SpeI site | 357 |
HrpB2-R | CCGCTCGAGCGGGCATCAACTTGATCTGCT | XhoI site | ||
HrcB2-ext-R | GGAAAGCGGGTCGTTGTTGG | To be used with ProF | 896 | |
hrpG | HrpG-F | GGACTAGTCCTGCGAGCTGCTGATCTTCGAT | SpeI site | 467 |
HrpG-R | CCGCTCGAGCGGTTGTAGATGTGCTGCTCCATGGT | XhoI site | ||
HrpG-ext-F | CACCAACCAGCATCCTGCTC | To be used with ProR | 1,680 | |
hrpX | HrpX-F | GGACTAGTCCGCCTACAGCTACATGATCACCAA | SpeI site | 206 |
HrpX-R2 | CCGCTCGAGCGGCTTCGGCCAGCAGTTCGT | XhoI site | ||
HrpX-ext-R | TTACCGCTGCAAGGTCTCCATCGG | To be used with ProF | 446 | |
ProR | TTCACGGGTTGGGGTTTCTACA | pVO155 primer | ||
ProF | GAGATCCCCAGCCCGCCTAATG | pVO155 primer |
For each target gene, the two first primers indicated were designed to construct the mutation. The third primer, which needs to be used with ProF or ProR, was designed for the validation of the mutation and for the specific identification of mutated strains.
Underlined sequences indicate the relevant restriction site.